- Home
- ADD vs PHIO Comparison
ADD vs PHIO Comparison
Compare ADD & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADD
- PHIO
- Stock Information
- Founded
- ADD 2002
- PHIO 2011
- Country
- ADD United States
- PHIO United States
- Employees
- ADD N/A
- PHIO N/A
- Industry
- ADD Engineering & Construction
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ADD Consumer Discretionary
- PHIO Health Care
- Exchange
- ADD Nasdaq
- PHIO Nasdaq
- Market Cap
- ADD 2.4M
- PHIO 2.3M
- IPO Year
- ADD N/A
- PHIO N/A
- Fundamental
- Price
- ADD $2.39
- PHIO $2.61
- Analyst Decision
- ADD
- PHIO Strong Buy
- Analyst Count
- ADD 0
- PHIO 1
- Target Price
- ADD N/A
- PHIO $36.00
- AVG Volume (30 Days)
- ADD 555.6K
- PHIO 30.8K
- Earning Date
- ADD 12-27-2024
- PHIO 11-14-2024
- Dividend Yield
- ADD N/A
- PHIO N/A
- EPS Growth
- ADD N/A
- PHIO N/A
- EPS
- ADD N/A
- PHIO N/A
- Revenue
- ADD $2,830,442.00
- PHIO N/A
- Revenue This Year
- ADD N/A
- PHIO N/A
- Revenue Next Year
- ADD N/A
- PHIO N/A
- P/E Ratio
- ADD N/A
- PHIO N/A
- Revenue Growth
- ADD N/A
- PHIO N/A
- 52 Week Low
- ADD $2.27
- PHIO $2.17
- 52 Week High
- ADD $185.00
- PHIO $10.35
- Technical
- Relative Strength Index (RSI)
- ADD 27.57
- PHIO 48.74
- Support Level
- ADD $2.75
- PHIO $2.58
- Resistance Level
- ADD $3.23
- PHIO $2.91
- Average True Range (ATR)
- ADD 0.53
- PHIO 0.21
- MACD
- ADD 1.07
- PHIO 0.01
- Stochastic Oscillator
- ADD 0.48
- PHIO 26.76
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.